DRUG ALLERGIES WT: KG

Size: px
Start display at page:

Download "DRUG ALLERGIES WT: KG"

Transcription

1 DRUG AND TREATMENT Acute Diabetic Ketoacidosis Condition/Status ***(NOTE)*** For purpose of this DKA Regimen, DKA is considered clear only when the CO2 is GREATER than 18 meq/l and the anion gap is LESS than 12 mmol/l Patient Status Inpatient Patient Status: Inpatient, Level of Care: Intensive Care (8) Place in Observation Patient Status: Outpatient- Refer for Observation Status, Level of Care: Intensive Care (8) Diet Diet Order. Nursing Orders Notify Provider Notify ordering physician if Blood glucose LESS than 90 mg/dl while Acute Phase DKA orders are active, Blood glucose decreases by GREATER than 100 mg/dl per hour while on insulin infusion, Comments: Potassium level LESS than 2.3 meq/dl or GREATER than 6 meq/dl Phosphorus level LESS than 0.5 mg/dl Magnesium level LESS than 1 mg/dl Ionized Calcium level LESS than 3.4 mg/dl Urine output LESS than 0.5 ml/kg/hour Sodium level LESS than 130 meq/dl or GREATER than 155 meq/dl Serum Osmolality decreases GREATER than 12 mosm/kg over 4 hours Development of pulmonary edema (i.e. rales), headache or confusion Diabetic Ketoacidosis Reference Materials Communication Order Monitor potassium, magnesium, phosphorus, and ionized calcium levels while on an insulin infusion and replace as per SUB Acute DKA Electrolyte Replacement or as ordered Plan Progression Orderable Initiate POST ACUTE DKA phase and discontinue ACUTE DKA phase ONLY when the anion gap is LESS than 12 mmol/l and CO2 is GREATER than 18mEq/L and when the patient can attempt PO intake. Comments: Continue IV fluid orders until patient tolerates greater than 50% of first meal or otherwise ordered by physician. Continue Insulin infusion until 1 hour AFTER long acting insulin is administered and/or home insulin infusion pump is restarted or if patient to remain. Blood Glucose Monitor POC Q1H Comments: Check finger stick blood glucose every hour while on insulin infusion. Obtain lab glucose if finger stick blood glucose does NOT agree with clinical assessment.*******************************************************************when finger stick blood glucose is LESS than 250 mg/dl: Creatinine LESS than or EQUAL to 2 mg/dl -- Change IV fluids to D5 1/2 NS with 20 KCl Creatinine GREATER than 2 mg/dl -- Change IV fluids to D5 1/2 NS******************************************************************* Medications ***(NOTE)*** Cancel all prior IV fluid and insulin orders. Insulin (Regular) 100 units/ns 100mL (IVS)* NS (Insulin) Initial Multiplier: 0.03 BG Target Range: 140 mg/dl-180 mg/dl IV iv Titrate per algorithm Comments: Insulin Infusion Guidelines (DKA)Target Blood Glucose Range mg/dl Initial Infusion Rate: Initial Rate= Start Insulin infusion at 0.14 units/kg per hour Page 1 of 5

2 DRUG AND TREATMENT when potassium level is 3.2 meq/l or GREATER: - Flush tubing with 20mL of Insulin Infusion PRIOR to starting infusion - Administer via an infusion device piggybacked into IV fluids Rate in units/hour = (BG-60) x 0.03: - BG = Current Blood Glucose = Multiplier Hourly Dose Adjustments: If BG is within target range, do not change multiplier BUT do recalculate dose. Adjust multiplier as follows: If BG is GREATER than 180 mg/dl, increase the multiplier by 0.01If BG is LESS than 140 mg/dl reduce multiplier by 0.01For BG GREATER than 400 mg/dl, use 400 as Maximum BG for Calculation. If the calculated rate is LESS than 1 unit/hour, continue patient on insulin infusion at 1 unit/hour and adjust rate hourly as above. If BG is within target range, do not change multiplier but do recalculate dose. Insulin dose MUST be calculated hourly even if multiplier does not changexxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxxxxxxxxxxxxxxxxxxxxxdo NOT stop insulin infusion until anion gap is LESS than 12 mmol/l and CO2 is GREATER than 18 meq/l AND a long acting subcutaneous insulin (i.e. Levemir, Lantus, NPH, Novolog Mix 70/30) is administered OR Insulin Pump is resumed.xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxxxxxxxxxxxxxxxxxxxxxxxhypoglycemia Treatment For Blood Sugar LESS than 120 mg/dl: administer D50W as per order details insulin regular (human) IV drip 100 unit SUB Acute DKA IV Fluid Regimen (SUB)* ***Reminder: Order SUB Acute DKA IV Fluid Regimen (SUB) on a separate form*** Notify Provider (BMCB) Notify Provider (BMCD) Notify Provider (BMCN) Call Physician for any abnormal lab results to obtain orders for electrolyte replacement Notify Provider (BMCS) SUB Acute DKA Electrolyte Replacement (SUB)* ***Reminder: Order SUB Acute DKA Electrolyte Replacement (SUB) on a separate form*** D50W (Insulin Infusion Orders) 50 ml IV PUSH syringe PRN, PRN Low Blood Sugar Comments: For Blood Sugar LESS than 120 mg/dl while on insulin infusion:1. Give Dextrose 50% 50mL 2. If Serum Creatinine is LESS than or EQUAL to 2 mg/dl Change IV Fluids to D10 ½ Normal Saline at 250 ml/hour and notify Pharmacy STAT3. If Serum Creatinine is GREATER than 2 mg/dl Change IV Fluids to D10 ½ Normal Saline at 250 ml/hour and notify Pharmacy STAT4. Recheck finger stick blood glucose in 30 minutes Repeat Dextrose 50% 50 ml IV every 30 minutes as needed to keep finger stick blood glucose GREATER than or EQUAL to 120 mg/dl Page 2 of 5

3 DRUG AND TREATMENT Laboratory CHEM 7 Magnesium Level Phosphorus Ionized Calcium Level Consults Consult Diabetes-Adult Soon, Teach Diabetic Ketoacidosis Consult Dietitian Other - See Special Instructions, Diabetic Ketoacidosis Consult Pharmacy Other - See Special Instructions, DKA: Discontinue all prior IV fluid and insulin orders Post-Acute Diabetic Ketoacidosis Non Categorized ***(NOTE)*** Recommend this phase to be placed in PLANNED state-to be initiated by nurse when patient meets defined parameters in Plan Progression Orderable. Diet Patient to be Initiated on a Diet ***(NOTE)*** For patients with anion gap LESS than 12 mmol/l and CO2 GREATER than 18 meq/l and patients that CAN attempt oral intake, choose diet order below: Diet Order 1800 kcal (DEF)* 1500 kcal 2000 kcal 2200 kcal 2400 kcal Patient to be kept ***(NOTE)*** For patients with anion gap LESS than 12 mmol/l and CO2 GREATER than 18 meq/l and patient who will remain, select BOTH Communication and order. Communication Order Change IV fluid rate to 150 ml/hour in patients who will remain. Continue Insulin infusion per Acute Phase algorithm. Diet Order. Nursing Orders Page 3 of 5

4 DRUG AND TREATMENT Plan Progression Orderable Initiate POST ACUTE DKA phase and discontinue ACUTE DKA phase ONLY when the anion gap is LESS than 12 mmol/l and CO2 is GREATER than 18mEq/L. Comments: Continue IV fluid orders until patient tolerates greater than 50% of first meal or otherwise ordered by physician. Continue Insulin infusion until 1 hour AFTER long acting insulin is administered and/or home insulin infusion pump is restarted or if patient to remain. Blood Glucose Monitor POC AC&BEDTIME Medications GEN Correction Insulin (Sliding Scale) (SUB)* ***Reminder: Order GEN Correction Insulin (Sliding Scale) (SUB) on a separate form*** Basal Insulins insulin detemir (Levemir) unit inj SUBCUT BEDTIME (DEF)* Comments: First dose NOW. Do NOT hold when patient is. If fingerstick blood glucose is less unit inj SUBCUT DAILY, Start: 0900 Comments: First dose NOW. Do NOT hold when patient is. If fingerstick blood glucose is less unit inj SUBCUT Q12H Comments: First dose NOW. Do NOT hold when patient is. If fingerstick blood glucose is less insulin glargine (Lantus) unit inj SUBCUT BEDTIME (DEF)* unit inj SUBCUT DAILY unit inj SUBCUT Q12H Insulin isophane (insulin NPH human) unit inj SUBCUT BIDAC (DEF)* unit inj SUBCUT BEDTIME&AM unit inj SUBCUT BEDTIME Insulin aspart-insulin aspart protamine (NovoLog Mix 70/30) unit inj SUBCUT BIDAC Comments: First dose NOW. HOLD if patient is and call physician for other insulin orders Page 4 of 5

5 DRUG AND TREATMENT Consults Consult Physician (BMCB) Consult Physician (BMCD) Consult Physician (BMCS) Page 5 of 5

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG DRUG AND TREATMENT *****ALSO ORDER SUB ACUTE DKA IV FLUIDS REGIMEN & SUB ACUTE ELECTROLYTE REPLACEMENT on separate forms ***** Condition/Status For purpose of this DKA Regimen, DKA is considered clear

More information

ALL orders are active unless: 1. Order is manually lined through to inactivate 2. Orders with check boxes ( ) are unchecked

ALL orders are active unless: 1. Order is manually lined through to inactivate 2. Orders with check boxes ( ) are unchecked Available at: BMC-B BMC-D BMC-N BMC-S Condition/Status ***(NOTE)***For purpose of this DKA Regimen, DKA is considered clear only when the CO2 is GREATER than 18 meq/l and the anion gap is LESS than 12

More information

DONATION AFTER CARDIAC DEATH PLAN

DONATION AFTER CARDIAC DEATH PLAN DONATION AFTER CARDIAC DEATH PLAN Diagnosis Weight Allergies Patient Care Core Body Temperature Monitoring Maintain body temp 96-99 degrees Farenheit. Utilize Hyper/Hypothermia blanket prn Insert Gastric

More information

ADMIT DIABETIC KETOACIDOSIS (DKA) PLAN - Phase: Begin Immediately/Emergency Center

ADMIT DIABETIC KETOACIDOSIS (DKA) PLAN - Phase: Begin Immediately/Emergency Center - Phase: Begin Immediately/Emergency Center Weight PHYSICIAN S Allergies Admit/Discharge/Transfer Patient Status Requested Location: MICU, Pt Status: Inpatient (LOS > 2 midnights) Requested Location: 5E

More information

Arterial blood gas Capillary blood glucose every hour. Continue to monitor hourly capillary blood glucose as per protocol (See Appendix A and B)

Arterial blood gas Capillary blood glucose every hour. Continue to monitor hourly capillary blood glucose as per protocol (See Appendix A and B) Page 1 of 6 Hyperglycemic Emergency Management (DKA/HHS 1 ) - Adult PATIENT PRESENTATION Patient with history of Type 1 or 2 Diabetes Mellitus or presenting with polyuria, polydipsia, nausea/ vomiting,

More information

SHINE Study PowerChart Order Set CONTROL

SHINE Study PowerChart Order Set CONTROL SHINE Study PowerChart Order Set CONTROL Orders Patient Care Component Blood Glucose Details Hypoglycemia: For BG

More information

Arterial blood gas Capillary blood glucose every hour. Continue to monitor hourly capillary blood glucose as per protocol (See Appendix A and B)

Arterial blood gas Capillary blood glucose every hour. Continue to monitor hourly capillary blood glucose as per protocol (See Appendix A and B) Page 1 of 6 Hyperglycemic Emergency Management (DKA/HHS 1 ) - Adult PATIENT PRESENTATION Patient with history of Type 1 or 2 Diabetes Mellitus or presenting with polyuria, polydipsia, nausea/ vomiting,

More information

Physician Orders PEDIATRIC: LEB DKA Diabetes Mellitus Admit Plan

Physician Orders PEDIATRIC: LEB DKA Diabetes Mellitus Admit Plan Initiate Orders Phase Non Categorized R Powerplan Open Care Sets/Protocols/PowerPlans Initiate Powerplan Phase Phase: Admit DKA Two-Bag Calculations Phase, When to Initiate: Initiate Powerplan Phase Phase:

More information

DKA Adult ICU Powerplan

DKA Adult ICU Powerplan DKA Adult ICU Powerplan Key Points for ED to ICU DKA power plan In addition to NS fluids and maintenance the regular insulin drip will either already be infusing from ED or needs to be initiated. Regular

More information

ADVOCATE CHRIST MEDICAL CENTER DKA (DIABETIC KETOACIDOSIS) TREATMENT GUIDELINES

ADVOCATE CHRIST MEDICAL CENTER DKA (DIABETIC KETOACIDOSIS) TREATMENT GUIDELINES ADVOCATE CHRIST MEDICAL CENTER DKA (DIABETIC KETOACIDOSIS) TREATMENT GUIDELINES DEFINITION -Glucose >250 mg/dl*, anion gap > 16, + ketones * Glucose < 250 does not exclude DKA especially if anion gap >

More information

Physician Orders PEDIATRIC: LEB ED Hx of DKA with Hyperglycemia Plan

Physician Orders PEDIATRIC: LEB ED Hx of DKA with Hyperglycemia Plan LEB ED Triage Hx of DKA w Hyperglycemia Non Categorized Criteria for use: Patients less than 18 years of age with known or suspected Diabetes Mellitus and blood glucose greater than 300mg/dL.(NOTE)* Vital

More information

Pharmacy Plan Guidance

Pharmacy Plan Guidance Pharmacy Plan Guidance The pharmacy plan is a tool used during the site readiness process to develop and document the site-specific procedures for study drug ordering, labeling and dispensing for the SHINE

More information

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG DRUG AND TREATMENT Available ONLY at: BMC-B BMC-D BMC-N BMC-S Nursing Orders Communication Order If CVP unavailable, administer fluid boluses every 30 minutes except monitor O2 requirements Comments: Every

More information

LIBERTYHEALTH. Jersey City Medical Center Department of Patient Care Services. Approved by Policy Committee:

LIBERTYHEALTH. Jersey City Medical Center Department of Patient Care Services. Approved by Policy Committee: LIBERTYHEALTH Jersey City Medical Center Department of Patient Care Services Guidelines: CRITICAL CARE INSULIN PROTOCOL (MICU/SICU, CCU, ED) Developed by: Pharmacy Dept Approved by: Rita Smith, DNP Senior

More information

Diabetic Ketoacidosis

Diabetic Ketoacidosis October 2015 Michael T. McDermott MD Director, Endocrinology and Diabetes Practice University of Colorado Hospital Case History HPI: 24 yo man with recent 8 lb. weight loss, increased thirst and frequent

More information

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended course of treatment for patients with the identified health

More information

DKA/HHS Pathway Phase 1 (Adult) Insulin Potassium Bicarbonate

DKA/HHS Pathway Phase 1 (Adult) Insulin Potassium Bicarbonate Approved by Diabetes Steering Committee, MMC, 2015 DKA/HHS Pathway Phase 1 (Adult) DKA Diagnostic Criteria (See page 3 for more details): Blood glucose >250 mg/dl, Arterial ph

More information

Peripartum and Postpartum Management of Diabetes

Peripartum and Postpartum Management of Diabetes Peripartum and Postpartum Management of Diabetes General Principles Glucose goal ~ 100 mg/dl (70-110 mg/dl) Labor is EXERCISE with increased metabolic demands. Insulin requirements decrease however the

More information

DKA : Diabetic Ketoacidosis & HHS: Hyperlgycemic Hyperosmolar Syndrome Protocol. Glycemic Task Force September 2014

DKA : Diabetic Ketoacidosis & HHS: Hyperlgycemic Hyperosmolar Syndrome Protocol. Glycemic Task Force September 2014 DKA : Diabetic Ketoacidosis & HHS: Hyperlgycemic Hyperosmolar Syndrome Protocol Glycemic Task Force September 2014 Hyperglycemic Crises: Pathophysiology DKA HHS Hyperglycemia DKA HHS Umpierrez, In Shoemaker,

More information

Improving Inpatient Diabetes Care: Focus on Safe Use of Anti-diabetic Therapies

Improving Inpatient Diabetes Care: Focus on Safe Use of Anti-diabetic Therapies Improving Inpatient Diabetes Care: Focus on Safe Use of Anti-diabetic Therapies Leigh Briscoe-Dwyer, PharmD, BCPS, FASHP Chief Pharmacy and Medication Safety Officer North Shore Long Island Jewish Health

More information

SARASOTA MEMORIAL HOSPITAL NURSING PROCEDURE

SARASOTA MEMORIAL HOSPITAL NURSING PROCEDURE SARASOTA MEMORIAL HOSPITAL NURSING PROCEDURE TITLE: ISSUED FOR: DKA / HHNS PATIENTS REQUIRING INTRAVENOUS INSULIN DRIPS -ADULTS Nursing DATE: REVIEWED: PAGES: 12/14 5/18 1 of 8 RESPONSIBILITY: *RN (Renal/Diabetes/Wound

More information

Diabetic Ketoacidosis (DKA) Critical Care Guideline Two Bag System

Diabetic Ketoacidosis (DKA) Critical Care Guideline Two Bag System Critical Care Guideline Two Bag System Inclusion Criteria (Definition of DKA): Blood glucose (BG) > 200 mg/dl Acidosis (bicarbonate < 15 or blood gas ph < 7.3) Associated glycosuria, ketonuria &/or ketonemia

More information

COMPLIANCE WITH THIS DOCUMENT IS MANDATORY

COMPLIANCE WITH THIS DOCUMENT IS MANDATORY COVER SHEET `NAME OF DOCUMENT TYPE OF DOCUMENT at Shoalhaven Hospital Group Critical Care Procedure DOCUMENT NUMBER DATE OF PUBLICATION February 2018 RISK RATING Medium REVIEW DATE February 2021 FORMER

More information

DRUG ALLERGIES WT: KG

DRUG ALLERGIES WT: KG DRUG AND TREATMENT Available ONLY at: BMC-B BMC-D BMC-N BMC-S Non Categorized Quality Measure Sepsis Bundle Admit to Inpatient Patient Status: Inpatient, Level of Care: Intensive Care (8), Diagnosis: Please

More information

ST. DOMINIC-JACKSON MEMORIAL HOSPITAL JACKSON, MISSISSIPPI. CONTINUOUS RENAL REPLACEMENT THERAPY (CRRT) HEPARIN ANTICOAGULATION Page 1 of 5

ST. DOMINIC-JACKSON MEMORIAL HOSPITAL JACKSON, MISSISSIPPI. CONTINUOUS RENAL REPLACEMENT THERAPY (CRRT) HEPARIN ANTICOAGULATION Page 1 of 5 HEPARIN ANTICOAGULATION Page 1 of 5 Pharmacy Mnemonic: CRRTHEP1 PATIENT DATA: DIAGNOSIS: AKI ESRD Other: WEIGHT: Today: kg Admission Weight:: kg Dry Weight: kg Access TYPE: Temporary Dialysis Catheter

More information

Lynda Astbury Lead Diabetes Specialist Nurse

Lynda Astbury Lead Diabetes Specialist Nurse Lynda Astbury Lead Diabetes Specialist Nurse WARNING SIGNS AND SYMPTOMS Is patient Feeling unwell? Blood glucose level above 13mmol/L Or higher than the patients day to day readings (even if not eating)

More information

ALL orders are active unless: 1. Order is manually lined through to inactivate 2. Orders with check boxes ( ) are unchecked DRUG AND TREATMENT ORDERS

ALL orders are active unless: 1. Order is manually lined through to inactivate 2. Orders with check boxes ( ) are unchecked DRUG AND TREATMENT ORDERS Available at: ALL Adult Facilities Non Categorized SUB Protocol(SUB)* SUB Protocol Lab Orders(SUB)* ED Rainbow Tubes(SUB)* ***Reminder: Order ED Rainbow Tubes (SUB) as a separate form*** Nursing Orders

More information

Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Treatment Protocols. Askiel Bruno, MD, MS Protocol PI

Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Treatment Protocols. Askiel Bruno, MD, MS Protocol PI Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Treatment Protocols Askiel Bruno, MD, MS Protocol PI SHINE Synopsis Acute ischemic stroke

More information

PICU ADMIT DKA PLAN - Phase: Begin Immediately

PICU ADMIT DKA PLAN - Phase: Begin Immediately - Phase: Begin Immediately Diagnosis Weight Allergies Admit/Discharge/Transfer Patient Status Requested Location: PICU, Pt Status: Inpatient (LOS > 2 midnights) Requested Location: PICU, Pt Status: Observation

More information

TYPE 1 DIABETES MELLITIS CARE OF WOMEN IN BIRTHING SUITE

TYPE 1 DIABETES MELLITIS CARE OF WOMEN IN BIRTHING SUITE TYPE 1 DIABETES MELLITIS CARE OF WOMEN IN BIRTHING SUITE DEFINITION Type 1 Diabetes: described as a total lack of insulin produced by the pancreas for the requirements of the tissues. If left untreated,

More information

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG DRUG AND TREATMENT Available at: BMC-B BMC-D BMC-N BMC-S Condition/Status Patient Status Inpatient Patient Status: Inpatient, Level of Care: Med/Surg without Telemetry (1) (DEF)* Patient Status: Inpatient,

More information

DRUG ORDERING & DISPENSING:

DRUG ORDERING & DISPENSING: STUDY DRUG: List the study drugs that will be used at your site based on your hospital formulary 1. Insulin Humulin R 2. Insulin Humalog 3. Insulin Lantus DRUG SUPPLY & STORAGE: Since study drugs are not

More information

DRUG ALLERGIES WT: KG

DRUG ALLERGIES WT: KG DRUG AND TREATMENT Available at: BMC-B BMC-D BMC-N BMC-S Vital Signs Vital Signs Q4H (DEF)* Q2H Q1H Vital Signs Orthostatic Activity Activity Bedrest, for 12 hours then Up ad lib (DEF)* Bedrest, for 24

More information

Pediatric Intensive Care Unit (PICU) Pediatric Diabetic Ketoacidosis (DKA) Admission Order Set

Pediatric Intensive Care Unit (PICU) Pediatric Diabetic Ketoacidosis (DKA) Admission Order Set Discontinue all previous orders Weight: kg DKA admit order set is for initial management Ongoing management required based on frequent reassessment of TFI, fluid balance and lab results. Admit to PICU

More information

Glucose Management in the ICU: The Role of the Pharmacist

Glucose Management in the ICU: The Role of the Pharmacist Objectives Glucose Management in the ICU: The Role of the Pharmacist James Gilmore PharmD, BCPS Senior Pharmacist- Surgical Intensive Care Unit Brigham and Women s Hospital Boston, MA Evaluate primary

More information

LIFEGIFT BRAIN DEATH PLAN

LIFEGIFT BRAIN DEATH PLAN Diagnosis Weight Allergies Admit/Discharge/Transfer ***THIS PLAN IS TO BE ED ONLY ON THE LIFEGIFT ENCOUNTER, WITH DR LIFEGIFT AS THE ATTENDING*** Patient Status Pt Status: Inpatient (Inpatient only procedure)

More information

Please inform the Diabetes Nurse Specialist that this patient has been admitted within 24hrs of admission.

Please inform the Diabetes Nurse Specialist that this patient has been admitted within 24hrs of admission. Adult Diabetic Ketoacidosis Care Bundle (V1. Issued October 2014 Review October 2015) Improving patient care This pack includes: DKA Management Guideline Name: (Patient Addressograph) DOB: Hospital No:

More information

Type I Type II Insulin Resistance

Type I Type II Insulin Resistance Insulin An aqueous hormonal solution made in the pancreas. Affects metabolism by allowing glucose to leave the blood and enter the body cells, preventing hyperglycemia. It is measured in units, e.g. 100

More information

AACN PCCN Review. Endocrine

AACN PCCN Review. Endocrine AACN PCCN Review Endocrine Presenter: Carol A. Rauen, RN, MS, CCNS, CCRN, PCCN, CEN Independent Clinical Nurse Specialist & Education Consultant rauen.carol104@gmail.com Endocrine I. INTRODUCTION Disorders

More information

Managing Hyperglycaemia in Acute (Adult) Inpatients Requiring Enteral Feeding Guidelines

Managing Hyperglycaemia in Acute (Adult) Inpatients Requiring Enteral Feeding Guidelines Document Control Title Managing Hyperglycaemia in Acute (Adult) Inpatients Requiring Author Author s job title Specialist Nurse Consultant Physician Department Directorate Unscheduled Care Version Date

More information

Improving Glycemic Control in the Critical Care

Improving Glycemic Control in the Critical Care Improving Glycemic Control in the Critical Care Setting /Hospitalists Outline Review current guidelines Review current glycemic targets DKA Treatment Building a perfect glycemic control protocol Transition

More information

Pediatric Diabetic Ketoacidosis (DKA) General Pediatrics Admission Order Set

Pediatric Diabetic Ketoacidosis (DKA) General Pediatrics Admission Order Set Admitting MRP: Pediatrics: Dr. / Dr. on call to cover until 08:00 am Service: Medicine Team 1 Medicine Team 2 Medical subspecialty Diagnosis: Diabetic Ketoacidosis (DKA) Estimated length of stay Less than

More information

Learning Objectives. Perioperative SWEET Success

Learning Objectives. Perioperative SWEET Success Perioperative SWEET Success PERIOPERATIVE SWEET SUCCESS PRESENTED BY: KENDRA MARTIN, RN, BSN, CDE JENNIFER SIMPSON, RN, BC-ADM, MSN, CNS Disclosure to Participants Notice of Requirements For Successful

More information

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG Available at: BMC-B BMC-D BMC-N BMC-S Activity Activity Bedrest with BRP, with assistance at nurse's discretion (DEF)* Ambulate with Assistance Diet Communication Order Patient to remain NPO while in PACU

More information

PEDIATRIC LIFEGIFT BRAIN DEATH PLAN

PEDIATRIC LIFEGIFT BRAIN DEATH PLAN PHYSICIAN S Diagnosis Weight Allergies Admit/Discharge/Transfer THIS PLAN IS TO BE ED ONLY ON THE LIFEGIFT ENCOUNTER, WITH DR LIFEGIFT AS THE ATTENDING. Patient Status Pt Status: Inpatient (Inpatient only

More information

Intensive Insulin in the Intensive Care Unit

Intensive Insulin in the Intensive Care Unit TABLE OF CONTENTS Introduction to Intensive Insulin in Adult Critical Care Patients - UIMCC Guideline for Insulin Infusion in Adult ICU Patients - P&T Committee Formulary Action Intensive Insulin in the

More information

PHYSICIAN S ORDERS Page 1 of 1 Providence Hospital ICU Insulin Drip Protocol

PHYSICIAN S ORDERS Page 1 of 1 Providence Hospital ICU Insulin Drip Protocol DTE PROVIDENCE HOSPITL 6801 irport Boulevard, Mobile L 36608, PHYSICIN S ORDERS Page 1 of 1 Providence Hospital ICU Insulin Drip Protocol 1. Discontinue all previous insulin and oral diabetic medications

More information

Case TWO. Vital Signs: Temperature 36.6degC BP 137/89 HR 110 SpO2 97% on Room Air

Case TWO. Vital Signs: Temperature 36.6degC BP 137/89 HR 110 SpO2 97% on Room Air Mr N is a 64year old Chinese gentleman who is a heavy drinker, still actively drinking, and chronic smoker of >40pack year history. He has a past medical history significant for Hypertension, Hyperlipidemia,

More information

Diabetic Emergencies DKA, HHS, Hypoglycemia. Disclosure. Learning Objectives

Diabetic Emergencies DKA, HHS, Hypoglycemia. Disclosure. Learning Objectives Diabetic Emergencies DKA, HHS, Hypoglycemia October 2018 Michael T. McDermott MD Director, Endocrinology and Diabetes Practice University of Colorado Hospital Disclosure Michael McDermott has no conflict

More information

Guideline for Children with Type 1 or Type 2 Diabetes on Insulin Requiring Surgery or Sedation

Guideline for Children with Type 1 or Type 2 Diabetes on Insulin Requiring Surgery or Sedation CHILDREN S SERVICES Guideline for Children with Type 1 or Type 2 Diabetes on Insulin Requiring Surgery or Sedation Background Surgery places stress on the body and will alter glucose control and insulin

More information

Diabetic Ketoacidosis

Diabetic Ketoacidosis Diabetic Ketoacidosis Definition: Diabetic Ketoacidosis is one of the most serious acute complications of diabetes. It s more common in young patients with type 1 diabetes mellitus. It s usually characterized

More information

Technology for Diabetes: 101 Basic Rules of the Road. Karen Hamon RN, BSN, CDE Stephen Stone MD, FAAP Neil H. White, MD, CDE

Technology for Diabetes: 101 Basic Rules of the Road. Karen Hamon RN, BSN, CDE Stephen Stone MD, FAAP Neil H. White, MD, CDE Technology for Diabetes: 101 Basic Rules of the Road Karen Hamon RN, BSN, CDE Stephen Stone MD, FAAP Neil H. White, MD, CDE Quick Pump Facts! o Constant insulin supply o Pager-sized mini-computer worn

More information

The Hospitalized Child with Diabetes/Hyperglycemia: Don t Sugar Coat It

The Hospitalized Child with Diabetes/Hyperglycemia: Don t Sugar Coat It The Hospitalized Child with Diabetes/Hyperglycemia: Don t Sugar Coat It Cassie Brady, MD Assistant Professor of Pediatrics Division of Endocrinology and Diabetes Monroe Carell Junior Children s Hospital

More information

Physician Orders ADULT: Kidney-Panc/PancTransplant Post Op Plan

Physician Orders ADULT: Kidney-Panc/PancTransplant Post Op Plan Initiate Orders Phase Care Sets/Protocols/PowerPlans Initiate Powerplan Phase T;N, Phase: Kidney-Panc/Panc Transp Post Op Phase, When to Initiate: Kidney-Panc/Panc Transp Post Op Phase Vital Signs Vital

More information

ALL orders are active unless: 1. Order is manually lined through to inactivate 2. Orders with check boxes ( ) are unchecked DRUG AND TREATMENT ORDERS

ALL orders are active unless: 1. Order is manually lined through to inactivate 2. Orders with check boxes ( ) are unchecked DRUG AND TREATMENT ORDERS DRUG AND TREATMENT Available at: BMC-B BMC-D BMC-N BMC-S Vital Signs Vital Signs Q4H (DEF)* Q2H Q1H Vital Signs Orthostatic Activity Activity Bedrest, for 12 hours then Up ad lib (DEF)* Bedrest, for 24

More information

The principles of insulin adjustment guidance

The principles of insulin adjustment guidance The principles of insulin adjustment guidance Tips for insulin titration Blood glucose (BG) monitoring is needed to help identify the efficacy of treatment in diabetes. Monitor blood glucose according

More information

Physician Orders ADULT: Head and Neck Postoperative Plan

Physician Orders ADULT: Head and Neck Postoperative Plan Initiate Orders Phase Care Sets/Protocols/PowerPlans Initiate Powerplan Phase, Phase: Head and Neck Postoperative Phase, When to Initiate: Head and Neck Post Operative Phase, Monitor and Record T,P,R,BP,

More information

Diabetes: Inpatient Glucose control

Diabetes: Inpatient Glucose control Diabetes: Inpatient Glucose control Leanne Current, PharmD, BCPS This activity is funded through the Medicaid section 1115(a) Demonstration Texas Healthcare Transformation and Quality Improvement Program

More information

How to BBIT An Educational Resource for Prescribers AHS Adult Subcutaneous Basal Bolus Insulin Therapy (BBIT)

How to BBIT An Educational Resource for Prescribers AHS Adult Subcutaneous Basal Bolus Insulin Therapy (BBIT) How to BBIT An Educational Resource for Prescribers AHS Adult Subcutaneous Basal Bolus Insulin Therapy (BBIT) The Basics, New Concepts and Practical Pearls for Basal Bolus Insulin Therapy February 2018

More information

HAP PA-HEN Achieving More Together

HAP PA-HEN Achieving More Together HAP PA-HEN Achieving More Together Managing Hyperglycemia in the Hospital: Strategies for Safe and Effective Care Pennsylvania Patient Safety Authority Managing Hyperglycemia in the Hospital: Strategies

More information

Disclosure 1/16/2017. Michael R. Brennan D.O., M.S., F.A.C.E Director Beaumont Endocrine Center Chief of Endocrine Beaumont Grosse Pointe 1/16/2017 2

Disclosure 1/16/2017. Michael R. Brennan D.O., M.S., F.A.C.E Director Beaumont Endocrine Center Chief of Endocrine Beaumont Grosse Pointe 1/16/2017 2 Therapy For Diabetes Michigan Association of Osteopathic Family Physicians Mid-Winter Family Medicine Update Shanty Creek Resort, MI January 19-22nd 2017 Michael R. Brennan D.O., M.S., F.A.C.E Director

More information

Pre admission & surgery Pre-admission Nurses Association SIG Catherine Prochilo Credentialled Diabetes Nurse Educator Sat 23 March 2013

Pre admission & surgery Pre-admission Nurses Association SIG Catherine Prochilo Credentialled Diabetes Nurse Educator Sat 23 March 2013 Pre admission & surgery Pre-admission Nurses Association SIG Catherine Prochilo Credentialled Diabetes Nurse Educator Sat 23 March 2013 www.diabetesvic.org.au Plan/ overview Issue/ presenting problems

More information

In - Hospital Diabetes Care. A review and personal experience

In - Hospital Diabetes Care. A review and personal experience In - Hospital Diabetes Care A review and personal experience Hyperglycemia in the Hospital The Problem Hospitalizations with Diabetes http://www.cdc.gov/diabetes/statistics/dmany/fig1.htm Prevalence of

More information

Information for all patients taking insulin who are admitted to hospital on day of surgery

Information for all patients taking insulin who are admitted to hospital on day of surgery Information for all patients taking insulin who are admitted to hospital on day of surgery Exceptional healthcare, personally delivered Introduction Many patients are now admitted to hospital on the day

More information

Special Situations 1

Special Situations 1 Special Situations 1 Outline Continuous Nutrition Tube feeds TPN Steroids Pumps Perioperative BG Control 2 Patient receiving continuous TF or TPN Continuous nutrition coverage options: Analog q4hr Regular

More information

DIABETIC KETOACIDOSIS (DKA) K E M I A D E Y E R I, P G Y - 1

DIABETIC KETOACIDOSIS (DKA) K E M I A D E Y E R I, P G Y - 1 DIABETIC KETOACIDOSIS (DKA) K E M I A D E Y E R I, P G Y - 1 QUESTION # 1 7 year old boy comes to the ER with a 2 week history of abdominal pain and weight loss. Further history reveals polyuria and polydipsia,

More information

Physician Orders ADULT: Asthma and Bronchitis Plan

Physician Orders ADULT: Asthma and Bronchitis Plan Initiate Orders Phase Care Sets/Protocols/PowerPlans Initiate Powerplan Phase, Phase: Asthma and Bronchitis Phase, When to Initiate: Asthma and Bronchitis Phase Non Categorized Problem: Asthma Problem:

More information

DRUG ALLERGIES WT: KG

DRUG ALLERGIES WT: KG DRUG AND TREATMENT Available ONLY at: BMC-A BMC-B BMC-C BMC-D BMC-N BMC-S BMC-T Non Categorized SUB (SUB)* SUB Alert Protocol(SUB)* SUB Alert Protocol Lab Tests(SUB)* Quality Measure Sepsis Bundle Nursing

More information

Physician Orders PEDIATRIC: LEB Oral Maxillofacial Post Op Plan

Physician Orders PEDIATRIC: LEB Oral Maxillofacial Post Op Plan Initiate Orders Phase Care Sets/Protocols/PowerPlans Initiate Powerplan Phase Phase: LEB Oral Maxillofacial Postop Phase, When to Initiate: LEB Oral Maxillofacial Post Op Phase Admission/Transfer/Discharge

More information

Neurosurgery Pre-Op [1710] Patient Name MRN. General. Nursing. Case Request [ ] Case request operating room Scheduling/ADT, Scheduling/ADT [ ] Other

Neurosurgery Pre-Op [1710] Patient Name MRN. General. Nursing. Case Request [ ] Case request operating room Scheduling/ADT, Scheduling/ADT [ ] Other Neurosurgery Pre-Op [1710] Patient Name MRN General Case Request [ ] Case request operating room Scheduling/ADT, Scheduling/ADT Inpatient Only Procedure (Single Response) ( ) Admit to Inpatient Diagnosis:

More information

SARASOTA MEMORIAL HOSPITAL

SARASOTA MEMORIAL HOSPITAL SARASOTA MEMORIAL HOSPITAL TITLE: NURSING PROCEDURE CARE OF THE INTRAPARTUM PATIENT RECEIVING CONTINUOUS INTRAVENOUS INSULIN ADMINISTRATION (obs25) DATE: REVIEWED: PAGES: 9/93 12/17 1 of 5 PS1094 ISSUED

More information

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG Available at ALL facilities Non Categorized SUB ED Chest Pain: STEMI Protocol(SUB)* SUB ED Chest Pain: STEMI Protocol Lab Orders(SUB)* ED Rainbow Tubes(SUB)* ***Reminder: Order ED Rainbow Tubes (SUB) as

More information

Physician Orders. PED Endocrine General Admit Plan [X or R] = will be ordered unless marked out. [ ] No known allergies

Physician Orders. PED Endocrine General Admit Plan [X or R] = will be ordered unless marked out. [ ] No known allergies Height: cm Weight: kg Allergies: [ ] No known allergies [ ] Initiate Powerplan Phase T;N, Phase:PED Endo General Admit Phase Admission/Transfer/Discharge [ ] Admit Patient to Dr. Admit Status: [ ] Inpatient

More information

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG DRUG AND TREATMENT Non Categorized SUB Sub Phase (SUB)* Non Categorized Quality Measures STK Diet ED NPO Until Bedside Swallow Screen passed Nursing Orders Activate Code Stroke Vital Signs Q15MINS Int

More information

***SPECIAL CONSIDERATION:

***SPECIAL CONSIDERATION: ADULT ANESTHESIA POST-OP OUTPATIENT SURGERY PLAN Dx PHYSICIAN S Weight Allergies DETAILS Admit/Discharge/Transfer Return Patient to PACU Patient Care ***Patients who are at high risk for obstructive sleep

More information

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG DRUG AND TREATMENT Available at: ALL Adult Facilities Non Categorized SUB Protocol(SUB)* SUB Protocol Lab Orders(SUB)* ED Rainbow Tubes(SUB)* ***Reminder: Order ED Rainbow Tubes (SUB) as a separate form***

More information

Use this version only

Use this version only Integrated Care Pathway PAEDIATRIC DIABETIC KETOACIDOSIS (DKA) Use this version only Patient Label Details Ward: Consultant: Named Nurse: Date of Admission: Date of Discharge/Transfer: ALL STAFF TO WRITE

More information

HYPERGLYCEMIA MANAGEMENT PROTOCOL A BASAL/BOLUS REGIMEN. Kacy Aderhold, MSN, APRN-CNS, CMSRN

HYPERGLYCEMIA MANAGEMENT PROTOCOL A BASAL/BOLUS REGIMEN. Kacy Aderhold, MSN, APRN-CNS, CMSRN HYPERGLYCEMIA MANAGEMENT PROTOCOL A BASAL/BOLUS REGIMEN Kacy Aderhold, MSN, APRN-CNS, CMSRN Hyperglycemia Management Protocol Mimics the body s normal pancreas function, releasing a slow steady amount

More information

In-hospital management of diabetes

In-hospital management of diabetes Dr. Tom Elliott MBBS, FRCPC Medical Director 400-210 W Broadway phone: 604.683.3734 Vancouver, BC fax: 604.628.3821 V5Y 3W2 Canada email: moa@bcdiabetes.ca In-hospital management of diabetes General Management

More information

Physician Orders Pediatric: LEB ED Asthma Plan

Physician Orders Pediatric: LEB ED Asthma Plan LEB ED Triage Standing SOB/Wheeze Asthma Non Categorized Criteria: Patients greater than 2 years of age with a history of asthma or airway active disease or two or more previous illnesses treated with

More information

Clinical Guideline DKA

Clinical Guideline DKA Clinical Guideline DKA Pediatric Emergency & Critical Care Medicine! This guideline should not replace clinical judgment. Inclusion criteria: Known Diabetes Mellitus Concern for new onset Diabetes Mellitus

More information

Faculty. Disclosures. Prescribing. A Multidisciplinary Approach to Preventing Medication Errors Associated with Insulin Therapy. Learning Objectives

Faculty. Disclosures. Prescribing. A Multidisciplinary Approach to Preventing Medication Errors Associated with Insulin Therapy. Learning Objectives A Multidisciplinary Approach to Preventing Medication Errors Associated with Insulin Therapy Faculty Matthew Grissinger, RPh, FISMP, FASCP Director, Error Reporting Programs Institute for Safe Medication

More information

Diabetes Case Study: Co-morbidity of Nonadherence

Diabetes Case Study: Co-morbidity of Nonadherence Diabetes Case Study: Co-morbidity of Nonadherence Maureen Dever, MSN, CRNP, PPCNP.BC, CDE PENS 5/18 Comorbidity of Diabetes Case Study Objective: the learner will discuss an underreported comorbidity of

More information

Dosage and Calculation

Dosage and Calculation Dosage and Calculation Module for Common & Complex: Medical-Surgical Nursing TABLE OF CONTENTS: PAGE I. Abbreviation 2 II. Systems of Measurement 4 III. Methods of Calculations: Dimensional Analysis 8

More information

Improved IPGM: Demonstrating the Value to both Patients and Hospitals

Improved IPGM: Demonstrating the Value to both Patients and Hospitals Improved IPGM: Demonstrating the Value to both Patients and Hospitals Osama Hamdy, MD, PhD, FACE Medical Director, Inpatient Diabetes Program Joslin Diabetes Center Harvard Medical School, Boston, MA Cost

More information

Physician Orders PEDIATRIC: LEB Eating Disorder Admit Plan

Physician Orders PEDIATRIC: LEB Eating Disorder Admit Plan Initiate Orders Phase Care Sets/Protocols/PowerPlans Initiate Powerplan Phase Phase: LEB Eating Disorder Admit Phase, When to Initiate: When patient arrives to unit LEB Eating Disorder Admit Phase Admission/Transfer/Discharge

More information

Implementing Hospital Policies & Protocols

Implementing Hospital Policies & Protocols Implementing Hospital Policies & Protocols Jane Jeffrie Seley DNP MPH GNP BC-ADM CDE CDTC FAADE FAAN Division of Endocrinology, Diabetes & Metabolism NewYork-Presbyterian Hospital Weill Cornell Medicine

More information

APPENDIX American Diabetes Association. Published online at

APPENDIX American Diabetes Association. Published online at APPENDIX 1 INPATIENT MANAGEMENT OF TYPE 2 DIABETES No algorithm applies to all patients with diabetes. These guidelines apply to patients with type 2 diabetes who are not on glucocorticoids, have no

More information

Staff at the Nottingham Children s Hospital. Guidelines process.

Staff at the Nottingham Children s Hospital. Guidelines  process. Diabetes and Surgery Title of Guideline Contact Name and Job Title (author) Guideline for the management of children and young people with diabetes aged 18 or under requiring surgery Dr Priyha Santhanam,

More information

Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Treatment Protocols Special Situations. Askiel Bruno, MD, MS Protocol PI

Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Treatment Protocols Special Situations. Askiel Bruno, MD, MS Protocol PI Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Treatment Protocols Special Situations Askiel Bruno, MD, MS Protocol PI Hypoglycemia Protocol General Concepts The hypoglycemia prevention protocol

More information

Transition of Care in Hospitalized Patients with Hyperglycemia and Diabetes

Transition of Care in Hospitalized Patients with Hyperglycemia and Diabetes Transition of Care in Hospitalized Patients with Hyperglycemia and Diabetes Critically ill patients in the ICU Hospital Non-ICU Settings Home Guillermo E Umpierrez, MD, FACP, FACE Professor of Medicine

More information

Peri-Operative Guidelines for Management of Diabetes Patients

Peri-Operative Guidelines for Management of Diabetes Patients Peri-Operative Guidelines for Management of Diabetes Patients Target blood glucose 6-10 mmol/l for all patients Acceptable blood glucose 4-11 mmol/l for all patients Definitions Non-Insulin Glucose Lowering

More information

Basal Bolus Insulin Therapy Frequently Asked Questions

Basal Bolus Insulin Therapy Frequently Asked Questions 1. What is Basal Bolus Insulin Therapy (BBIT)? 2. What evidence supports the use of subcutaneous Basal Bolus Insulin Therapy? 3. Does Basal Bolus Insulin Therapy apply to all patients? 4. What s wrong

More information

Have participants measure their blood pressure daily at a standard time for two weeks. Obtain BP values from participant (fax, call, , mail).

Have participants measure their blood pressure daily at a standard time for two weeks. Obtain BP values from participant (fax, call,  , mail). Blood Pressure Management and Control Protocol BP Management: A) BP goal: Achieve blood pressure values less than 130/80mmHg. B) Process: Have participants measure their blood pressure daily at a standard

More information

Diabetes in Pregnancy

Diabetes in Pregnancy Diabetes in Pregnancy Ebony Boyce Carter, MD, MPH Division of Maternal Fetal Medicine Washington University School of Medicine Disclosures I have no financial disclosures to report. Objectives Review the

More information

Nothing to disclose. Disclosure

Nothing to disclose. Disclosure Nothing to disclose. Disclosure Inpatient Management of Diabetes Mellitus Cindy Chin, MD Pediatrics in the Red Rocks 2015 Objectives Name 3 diagnostic criteria for diabetes mellitus. Understand and apply

More information

Inpatient Diabetes Management: The Slippery Slope of Sliding Scale Insulin

Inpatient Diabetes Management: The Slippery Slope of Sliding Scale Insulin Inpatient Diabetes Management: The Slippery Slope of Sliding Scale Insulin David Newman, MD University of North Dakota School of Medicine Sanford Health Big Sky Conference 2017 Dr. David Newman, Personal/Professional

More information

Diabetes Medical Management Plan

Diabetes Medical Management Plan Diabetes Medical Management Plan 1 School District: School: School Year: Grade: Student Name: DOB: Provider Name: Phone #: Fax #: Blood Glucose Monitoring at School Blood Glucose Target Range: - mg/dl

More information

DRUG ALLERGIES WT: KG

DRUG ALLERGIES WT: KG DRUG AND TREATMENT Available ONLY at: BMC-B BMC-D BMC-N BMC-S NEURO Intracranial Hemorrhage (Factor VII) Condition/Status Patient Status Inpatient Patient Status: Inpatient, Level of Care: Intensive Care

More information